Outlook on the Respiratory Infection Diagnostic Global
Dublin, Oct. 06, 2021 (GLOBE NEWSWIRE) -- The "Respiratory Infection Diagnostic Markets by Technology, Plex, Place, Product and by Region With Covid-19...
Stay updated with breaking news from Bio Raises. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, Oct. 06, 2021 (GLOBE NEWSWIRE) -- The "Respiratory Infection Diagnostic Markets by Technology, Plex, Place, Product and by Region With Covid-19...
/PRNewswire/ -- The "Respiratory Infection Diagnostic Markets by Technology, Plex, Place, Product and by Region With Covid-19 Impact & Forecasting/Analysis,...
/PRNewswire/ -- The "Respiratory Infection Diagnostic Markets by Technology, Plex, Place, Product and by Region With Covid-19 Impact & Forecasting/Analysis,...
Published: May 05, 2021 By Mark Terry There’s money on the move and venture capital firms launch several biotech companies with hefty Series A financing rounds. Here’s a look. Esker Launches with $70 Million Series A San Francisco-based Esker Therapeutics, a Foresite Labs-incubated company, launched with a $70 million Series A financing. The round was led by Foresite Capital. The company focuses on autoimmune diseases and so-called precision therapies that target patients most likely to benefit from them. The company’s precision analytics platform is powered by Foresite Labs. ...